80
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Citrate Shows Specific, Dose-Dependent Lympholytic Activity In Neoplastic Cell Lines

, &
Pages 1657-1665 | Received 03 Jul 2003, Published online: 26 Aug 2009

References

  • Makoto, H., Yoshinar, K. and Akira, B.M. (2002) "Dysregulation of apoptosis and novel mechanism of defective apoptosis signal transduction in human B-cell neoplasms", Leukemia and Lympho-ma, 43, 243–249.
  • Opelz, G., Senga, D.P.S., Mickey, M.R. and Tarasalci, P.I. (1973) "Effect of blood transfusion on subsequent kidney transplants", Transplantation Proceedings, 5, 253–259.
  • Werner-Favre, C., Jeannet, M., Harder, F. and Montandon, A. (1979) "Blood transfusion, cytotoxic antibodies and kidney graft survival", Transplantation, 28, 343— 346.
  • Marquet, R.L. and Heyste, G.A. (1981) "Induction of Suppressor Cells by Donor-Specific Blood Transfusion and Heart Transplanta-tion in Rats", Transplantation, 31, 272–274.
  • Smith, M.D., Williams, J.D., Coles, G.A. and Salaman, J.R. (1981) "The effect of blood transfusion on T-suppressor cells in renal dialysis patients", Transplantation Proceedings, 13, 181–183.
  • Solheim, B.G. (1979) "The Role of Pretransplant Blood Transfu-sion", Transplantation Proceedings, 11, 138–144.
  • Tarasalci, P.I. (1984) "The beneficial transfusion effect on kidney graft survival attributed to clonal deletion", Transplantation, 37, 119— 125.
  • Koga, S., Luke, P.P., Specht, S.M., Rominsk, B., Jaquins-Gerstle, A., Hoffman, R.A., et al. (2000) "Inhibition of the allograft response by donor specific blood transfusion: association with reduced local TH cytolcines and nitric oxide but enhanced prostaglandin E2 production", Transplantation, 70, 1788–1796.
  • Hayman, N.H., Foster, R.S., DeMeules, J.E. and Costanza, M.C. (1985) "Blood transfusions and survival after lung cancer research", The American Journal of Surgery, 149, 502–507.
  • Miller, A.J., Call, E.J. and Whiting, C.R. (1993) "Comparison of organic acid salt for Clostridium botulinum control in an uncured turkey product", Journal of Food Products, 56, 958–962.
  • Bolan, C.D., Greer, SE., Ceccon, S.A., Oblitas, J.M., Rehak, N.N. and Leitman, S.F. (2001) "Comprehensive analysis of citrate effects during plateletpheresis in normal donor", Transfusion, 41, 1165 — 1171.
  • Lee, Y.L., Cesario, T., Owens, J., Shanbrom, E. and Thrupp, L.D. (2002) "Antibacterial activity of citrate and acetate", Nutrition, 18, 665–666.
  • Lee, Y.L., Thrupp, L., Owens, J., Cesario, T. and Shanbrom, E. (2001) "Bactericidal activity of citrate against gram-positive cocci", Applied Microbiology, 33, 349 — 351.
  • Yousefi, S., Vaziri, N., Carandang, G., Le, J., Vallanueva, C., Khonsari, S., et al. (1997) "Platelet activation factor and the production of human gamma interferon", Journal of Interferon and Cytokine Research, 17, 107–112.
  • Cesario, T., Slater, L. and Tilles, J. (1980) "Effect of antineoplastic agents on the antiviral activity of human interferon", Current chemotherapy and infection disease proceedings of the 11th ICC and the 19th ICAAC American Society of Microbiology, 1740 — 1742.
  • Murphy, S. (1990) "Glucose free primary anticoagulant for blood containing citrate ions" United States Patent number 4,925,665, May 15, 1990.
  • Berridge, M.J., Bootman, M.D. and Lipp, P. (1998) "Calcium-a life and death signal", Nature, 395, 645— 648.
  • Aktas, H., Fluciciger, R., Acosta, J.A., Savage, J.M., Palakurthi, S.S. and Halperin, J.A. (1998) "Depletion of intracellular Ca ± 2 stores, phosphorylation of eIF2a, and sustained inhibition of translation initiation mediate the anticancer effects of clotrimazole", Proceedings of the National Academy of Sciences of the United States of America, 95(14), 8280–8285.
  • Phillippoussis, F., Arguin C., Mateo V., Steff A. and Hugo P. (2003) "Monoglycerides induce apoptosis in human leukemic cells while sparing normal peripheral blood mononuclear cells", Blood, 101(1), 292–294.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.